Add BrightSurf on Google Email

World-first discovery of FLASH effect conditions using compact carbon ion synchrotron opens door to safer cancer therapy

Researchers have identified conditions under which ultra-high dose rate carbon ion beams can spare normal cells while maintaining tumor control, opening new possibilities for safer radiotherapy. The study reveals a cell-sparing effect under normoxic conditions using higher linear energy transfer values.

SourceThe University of Osaka·JournalAnticancer Research·TypeExperimental study·DateMay 13, 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

A breakthrough all-oral treatment for a rare but deadly strain of sleeping sickness is now available, revolutionizing care for patients in endemic countries. Fexinidazole Winthrop has been approved for use in several African countries and is being distributed by WHO, offering a safer alternative to existing treatments.

Head-to-head trial compares weight loss drugs

A 72-week clinical trial found tirzepatide to be more effective than semaglutide in reducing body weight and waist circumference. The study demonstrated that tirzepatide's dual mechanism of action, mimicking both GLP-1 and GIP hormones, is key to its superior performance.

SourceWeill Cornell Medicine·JournalNew England Journal of Medicine·DateMay 12, 2025

Chinese Neurosurgical Journal reports cases of successful recovery from subacute subdural hematoma using non-surgical therapy

Researchers investigated the efficacy of a combination of atorvastatin and dexamethasone in treating patients with subacute subdural hematoma (sASDH). The study found significant symptom improvement and no recurrence or progression of symptoms in all five patients treated with this regimen. Non-surgical interventions for sASDH are ofte...

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeCase study·DateMay 9, 2025

Mass General Brigham gene and cell therapy researchers present key findings from multiple innovative studies at ASGCT 2025

Researchers from Mass General Brigham presented key findings from multiple innovative studies on gene and cell therapy, focusing on rare diseases, brain cancer, and neurodegenerative disorders. The studies explored strategies to improve care delivery and accelerate translation from lab to clinic, with potential breakthroughs in treatin...

Chinese Neurosurgical Journal study explores new treatment strategy for patients with glioblastoma

Researchers investigated the clinical outcomes of concurrent TTFields therapy with CRT in patients with newly diagnosed glioblastoma, finding no significant difference in survival outcomes compared to adjuvant therapy. The study also showed comparable safety profiles for both treatment groups.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeExperimental study·DateMay 1, 2025

Nicotine pouch and e-cigarette use and co-use among U.S. youths

A cross-sectional study finds a doubling in nicotine pouch past-30-day use and an increase in pouch plus e-cigarette dual use, leading to decreased exclusive e-cigarette use among US 10th and 12th graders. Prioritizing surveillance, regulation, and prevention strategies is crucial for addressing pediatric nicotine pouch use.

SourceJAMA Network·JournalJAMA Network Open·DateApr 30, 2025

New AI model improves MS diagnostics

A new AI model developed by Uppsala University accurately diagnoses multiple sclerosis (MS) with an overall accuracy of 90%, identifying the transition from relapsing-remitting to secondary progressive MS in almost 87% of cases. This enables earlier diagnosis, reducing the risk of patients receiving ineffective medicines.

SourceUppsala University·Journalnpj Digital Medicine·TypeComputational simulation/modeling·DateApr 28, 2025

New machine algorithm could identify cardiovascular risk at the click of a button

Researchers developed an automated machine learning program to identify potential cardiovascular incidents and fall/fracture risks based on bone density scans. The algorithm shortened screening time and found moderate to high AAC levels in 58% of older individuals, placing them at high risk of heart attack and stroke.

SourceEdith Cowan University·JournalJournal of Bone and Mineral Research·TypeObservational study·DateApr 28, 2025

Rethinking stroke risk in patients with atherosclerotic carotid stenosis

A multicenter study found that radiologically unstable plaque, particularly intraplaque hemorrhage, significantly increases the risk of ischemic stroke and ocular symptoms in patients with symptomatic mild carotid stenosis. Surgical intervention, such as carotid endarterectomy, may be a protective factor for these patients.

SourceUniversity of Toyama·JournalJournal of Neurosurgery·TypeObservational study·DateApr 24, 2025

UTA professor explores healing power of music

Dr. Rhonda Winegar investigates the effectiveness of music therapy in supporting neurological care, including its ability to reduce anxiety and depression in Alzheimer's patients. Her research also highlights its potential to regulate heart rate and blood pressure, as well as improve motor function in individuals with Parkinson's disease.

SourceUniversity of Texas at Arlington·JournalThe Journal for Nurse Practitioners·TypeLiterature review·DateApr 16, 2025

Children born in lower-opportunity neighborhoods may face higher incidence rates of asthma with recurrent exacerbations, NIH study finds

A new NIH study found that children born in lower-opportunity neighborhoods are more likely to experience repeated asthma flares requiring emergency care. Non-Hispanic Black children have the highest incidence rates of severe childhood asthma, also known as asthma with recurrent exacerbations (ARE).

SourceEnvironmental influences on Child Health Outcomes·JournalJournal of Allergy and Clinical Immunology·TypeObservational study·DateApr 9, 2025

Cardioprotective glucose-lowering agents and dementia risk

A meta-analysis of randomized clinical trials found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a statistically significant reduction in all-cause dementia. Cardioprotective glucose-lowering therapies, however, did not show an overall reduction in dementia risk.

SourceJAMA Network·JournalJAMA Neurology·DateApr 7, 2025

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Despite free treatment in many countries, TB patients incur catastrophic costs due to hospitalization and lost income. A systematic review found that these costs can be prohibitively high for individuals in low-, middle-, and high-income settings.

SourcePLOS·JournalPLOS Global Public Health·DateApr 2, 2025